Skip to main content
. 2022 Jun 21;4(1):vdac097. doi: 10.1093/noajnl/vdac097

Table 2.

Clinical and Genetic Prognostic Factors

Univariate Analysis Multivariate Analysis
Prognostic Factor HR (95% CI) P value HR (95% CI) P value
Sex (male) 1.60 (0.93-2.75) .093 1.60 (0.91-2.83) .104
Age (>70 years) 2.53 (1.47-4.33) <.001* 2.72 (1.51-4.92) <.001*
KPS score (≤80 points) 1.46 (0.81-2.64) .210 1.76 (0.92-3.37) .088
PTR/biopsy 2.05 (1.20-3.48) .008* 1.85 (1.03-3.32) .041*
Unmethylated MGMTp 2.10 (1.24-3.57) .006* 3.00 (1.67-5.39) <.001*
PDGFRA gain/amp 2.22 (1.30-3.78) .003* 1.82 (1.00-3.31) .049*

KPS, Karnofsky Performance Status; PTR, partial tumor removal.

The symbol * indicates statistical significance.